The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have expanded their investigation into infant botulism cases linked to ByHeart formula, now covering 51 cases across 19 states. Authorities warned the contamination may date back to 2022. All affected products remain under recall.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.